Trial of synthetic steroid for preventing postmenopausal osteoporosis.
D045930:Anabolic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects*; D005260:Female; D006801:Humans; D008593:Menopause; D009652:Norpregnenes / Q000009:adverse effects / Q000627:therapeutic use*; D010024:Osteoporosis / Q000517:prevention & control*
D045930:Anabolic Agents; D009652:Norpregnenes; C027385:tibolone